chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 525434. A 27-year-old male patient, with no reported medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number not reported) in the left arm, concomitantly with an intramuscular injection of TYPHIM VI vaccine (lot number not reported) in the right arm and an intramuscular dose of BIOTHRAX vaccine (other manufacturer, lot number not reported) in the right arm on 20 February 2014. The patient did not receive any other medication. It was not reported whether the patient had received prior vaccination. The patient did not receive any other medication. It was not reported whether the patient had received prior vaccination. On 07 March 2014, 2 weeks post vaccination, the patient developed rash around trunk, arms, legs, but not on face/feet and genital area. Patient presented to Urgent Care Clinic and took BENADRYL and ALLEGRA as a corrective treatment. Lab data were not reported. Outcome was not reported. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 22.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Injection site erythema, Injection site inflammation, Injection site nodule
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 525515. A 22-year-old female patient, with a medical history of "exercised-induced urticarial/anaphylaxis", had received a percutaneous injection of ACAM2000 (lot number V04003A) in the right arm, concomitantly with an intramuscular injection of TYPHIM Vi (lot number G1541) in the left arm and an intramuscular dose of BIOTHRAX (other manufacturer, lot number FAV307) in the left arm on 01 July 2012. The patient did not receive any other medication and had no current illness. It was not reported whether the patient had received prior vaccination. On 01 July 2012, approximately 1 month post vaccination; she developed injection site erythema, injection site inflammation and injection site nodule. She had chronic local pink/red inflamed nodule measuring about 2.5cm x 2.0cm at site of inoculation on the right upper arm over deltoid. It was not reported whether the patient had received corrective treatment. Lab data were not reported. At the time of the report, the patient was not recovered. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only license smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Rash
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 526167. A 24-year-old male patient, with no medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number VV04003A) in the left arm, concomitantly with an injection of TYPHIM VI (lot number H1482, route and site of administration unknown) on 13 February 2014. It was not reported whether the patient had received other medications or prior vaccination. On 01 March 2014, approximately 16 days post vaccination; he developed rash on both hands and both elbows. The rash was not red, and not itchy. The patient went for an emergency visit on an unspecified date. It was not reported whether the patient had received corrective treatment. Lab data were not reported. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Pruritus, Rash erythematous
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 526167. A 24-year-old male patient, with no medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number VV04003A) in the left arm, concomitantly with an injection of TYPHIM VI (lot number H1482, route and site of administration unknown) on 13 February 2014. It was not reported whether the patient had received other medications or prior vaccination. On 01 March 2014, approximately 16 days post vaccination; he developed rash on both hands and both elbows. The rash was not red, and not itchy. The patient went for an emergency visit on an unspecified date. It was not reported whether the patient had received corrective treatment. Lab data were not reported. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 28.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Injection site pustule, Injection site scab
Clinical narrative: This case was received on 16 June 2013 via a third party query tool search on the VAERS database, under reference number 527022. A 28-year-old female patient had received the following vaccinations on 07 March 2014: ACAM2000 (SP Biologics Co. lot number VV4003A) in the left arm, TYPHIM VI (Sanofi Pasteur SA, lot number G1124) in the left arm, and BIOTHRAX (Emergent, lot number FAV328A). On 27 March 2014, the patient was seen in a clinic with concerns of healing of the smallpox vaccine site in left upper extremity. The scab had started to form, but came off and now the center of the Jennerian pustule is still moist and yellow and slightly concave on Day 20. The patient covered the area with occlusive waterproof bandage to prevent air circulation. The patient's other medications, current illnesses and history were reported as none. Outcome was unknown. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dermatitis, Rash, Rash pruritic, Vaccination complication
Clinical narrative: This case was received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 527024. A 23 year-old male patient with no past medical history had received the following vaccinations on 07 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration was unknown)), a Typhoid vaccine (lot number G1124) and route of administration reported as oral however route and site were unknown)) and a dose 0 BIOTHRAX (Emergent, lot number FAV328A) route and site of administration were unknown)) and 19 days later on 26 March 2014, experienced an itchy rash on palms of hands and soles of feet. According to the report, no aphthous ulcer in buccal mucosa. No fever, systemic malaise, CP (chest pain) or SOB (shortness of breath). The patient was evaluated in the emergency room. The patient was diagnosed with non-specific benign dermatitis. Lab data, other medications, current illnesses and history were reported as none. Prior vaccinations were not reported. Outcome was recovered. Note: Papulovesicular/pruritic was mentioned in the case narrative and coded as rash papulovesicular. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dermatitis, Rash papular, Rash pruritic
Clinical narrative: This case was received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 527024. A 23 year-old male patient with no past medical history had received the following vaccinations on 07 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration was unknown)), a Typhoid vaccine (lot number G1124) and route of administration reported as oral however route and site were unknown)) and a dose 0 BIOTHRAX (Emergent, lot number FAV328A) route and site of administration were unknown)) and 19 days later on 26 March 2014, experienced an itchy rash on palms of hands and soles of feet. According to the report, no aphthous ulcer in buccal mucosa. No fever, systemic malaise, CP (chest pain) or SOB (shortness of breath). The patient was evaluated in the emergency room. The patient was diagnosed with non-specific benign dermatitis. Lab data, other medications, current illnesses and history were reported as none. Prior vaccinations were not reported. Outcome was recovered. Note: Papulovesicular/pruritic was mentioned in the case narrative and coded as rash papulovesicular. Documents held by sender: none.
Age: 32.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Abortion missed, Human chorionic gonadotropin, Maternal exposure before pregnancy, Ultrasound scan vagina abnormal, Uterine dilation and curettage
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527343. A 32-year-old gravida, 1, para 0 female patient with no reported medical history and no concomitant medications received the following vaccinations on an unspecified date in December 2013: ACAM2000 (lot number VV04003A), TYPHIM Vi (lot number H14811), and BIOTHRAX (lot number FAV343), four days after her last menstrual period. She had also received INFLUENZA (lot number not reported) in November 2013. The patient was determined to be pregnant 22 days post-vaccination; estimated date of conception was 10 days post-vaccination. Human chorionic gonadotropin (hCG) was 641.1 at 3 weeks, 5 days estimated gestation age; hCG was 100,765 at 7 weeks, 6 days estimated gestation age. At 11 weeks 1 day estimated gestational age (also reported as February 2014), the patient experienced a missed abortion. An ultrasound at that time demonstrated crown rump length (CRL) of 0.65 cm, 0.45 cm with no cardiac activity and a collapsing gestational site. She was hospitalized and underwent dilation and curettage, and was treated with oxycodone hcl/acetaminophen, ibuprofen, and methylergonovine maleate. The event was considered to be resolved in March 2014. Of note, the patient had been contacted by an unknown investigator for possible enrollment in an ongoing pregnancy registry. That investigator felt that the event could be possibly related to vaccine administration. There may be a discrepancy between the event date field and the onset date information in the free text narrative in the data reported. Latency has been calculated using the event date.
Age: 32.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Abortion missed, Foetal heart rate abnormal, Human chorionic gonadotropin increased, Maternal exposure before pregnancy, Ultrasound antenatal screen abnormal
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527343. A 32-year-old gravida, 1, para 0 female patient with no reported medical history and no concomitant medications received the following vaccinations on an unspecified date in December 2013: ACAM2000 (lot number VV04003A), TYPHIM Vi (lot number H14811), and BIOTHRAX (lot number FAV343), four days after her last menstrual period. She had also received INFLUENZA (lot number not reported) in November 2013. The patient was determined to be pregnant 22 days post-vaccination; estimated date of conception was 10 days post-vaccination. Human chorionic gonadotropin (hCG) was 641.1 at 3 weeks, 5 days estimated gestation age; hCG was 100,765 at 7 weeks, 6 days estimated gestation age. At 11 weeks 1 day estimated gestational age (also reported as February 2014), the patient experienced a missed abortion. An ultrasound at that time demonstrated crown rump length (CRL) of 0.65 cm, 0.45 cm with no cardiac activity and a collapsing gestational site. She was hospitalized and underwent dilation and curettage, and was treated with oxycodone hcl/acetaminophen, ibuprofen, and methylergonovine maleate. The event was considered to be resolved in March 2014. Of note, the patient had been contacted by an unknown investigator for possible enrollment in an ongoing pregnancy registry. That investigator felt that the event could be possibly related to vaccine administration. There may be a discrepancy between the event date field and the onset date information in the free text narrative in the data reported. Latency has been calculated using the event date.
Age: 32.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Ultrasound scan vagina, Uterine dilation and curettage
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527343. A 32-year-old gravida, 1, para 0 female patient with no reported medical history and no concomitant medications received the following vaccinations on an unspecified date in December 2013: ACAM2000 (lot number VV04003A), TYPHIM Vi (lot number H14811), and BIOTHRAX (lot number FAV343), four days after her last menstrual period. She had also received INFLUENZA (lot number not reported) in November 2013. The patient was determined to be pregnant 22 days post-vaccination; estimated date of conception was 10 days post-vaccination. Human chorionic gonadotropin (hCG) was 641.1 at 3 weeks, 5 days estimated gestation age; hCG was 100,765 at 7 weeks, 6 days estimated gestation age. At 11 weeks 1 day estimated gestational age (also reported as February 2014), the patient experienced a missed abortion. An ultrasound at that time demonstrated crown rump length (CRL) of 0.65 cm, 0.45 cm with no cardiac activity and a collapsing gestational site. She was hospitalized and underwent dilation and curettage, and was treated with oxycodone hcl/acetaminophen, ibuprofen, and methylergonovine maleate. The event was considered to be resolved in March 2014. Of note, the patient had been contacted by an unknown investigator for possible enrollment in an ongoing pregnancy registry. That investigator felt that the event could be possibly related to vaccine administration. There may be a discrepancy between the event date field and the onset date information in the free text narrative in the data reported. Latency has been calculated using the event date.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: C-reactive protein, C-reactive protein increased, Chest X-ray normal, Dyspnoea, Monocyte count increased
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Myocarditis, Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Arteriogram coronary normal, Blood creatine phosphokinase MB increased, C-reactive protein increased, Catheterisation cardiac, Chest X-ray normal
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest pain, Dyspnoea, Echocardiogram normal, Electrocardiogram abnormal, Exercise test
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Heart rate increased, Pain, Painful respiration, Red blood cell sedimentation rate increased, Troponin I increased
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Ventricular hypertrophy
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: C-reactive protein, Chest X-ray normal, Dyspnoea, Monocyte count increased, Myocarditis
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Myocarditis, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 527631. A 22 year-old male patient with a history of substance abuse had received the following vaccinations on 24 March 2014: a dose 0 ACAM2000 (lot number VV04003A) site of administration unknown)), a dose 0 intramuscular injection of TYPHIM VI, lot number J05201 (site of administration unknown) and a dose 0 intramuscular injection of BIOTHRAX (lot number FAV365A site of administration unknown), and ten days later on 03 April2014, experienced difficulty breathing, went to the ER and was diagnosed with Myocarditis. Lab data included a normal chest x-ray, CRP 5.8, ESR 19, WBC 12.2 and monocytes 11.6. Other medications and current illnesses were none. Prior vaccinations were not reported. Outcome was unknown. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dizziness, Feeling abnormal, Hypoaesthesia oral
Clinical narrative: This case was received on 31 July 2014 via a third party query tool search on the VAERS database, under reference number 528608. A 23 year-old male patient had received the following vaccines on 16 April 2014: a right arm injection of ACAM2000 (lot number VV04003A), an intramuscular right arm injection of Typhoid vaccine lot number J16291, and a left arm intramuscular injection of Anthrax vaccine (Emergent) lot # FAV349A. On the same day of vaccination, the patient showed no immediate adverse reactions and was directed to sit in waiting area at front of clinic for 20 minutes. After 10 minutes, the patient complained of a 'weird numbness' on the left side of his mouth. When inquiries into the 'weird' feeling he was having were made, it was found that the patient's buccal area felt 'like when you get the needles at the dentist'. At that time he also reported being 'kind of lightheaded'. His feet were elevated, a cold compress was applied to his neck, vitals done, and the supervising provider was called over to evaluate. A series of checks to gauge the area and severity of numbness was done. The numbness was localized to left buccal area. Due to complaints of 'dizziness' the patient was escorted back to the nurses' area and placed in modified Trendelenburg position with a cold compress to back of neck. Vitals were obtained and "WNL" for the patient and the patient remained monitored until 1222PM. The patient's other medications were reported as Lidocaine 5% patch to affected area 12 hours on and 12 hours off and Hydroxyzine 25 mg, 2 tabs hs. The patient neither reported nor displayed any signs or symptoms of active or acute illness. The patient denied any adverse feeling immediately after immunizations. The patient has a history of asplenia, chronic seasonal allergies, a history of astigmatism and myopia. Lab data was reported as none. No further information was available at the time of the report. The patient's outcome was recovered, date not reported. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: TYP, YF, TYP, YF
Symptoms: Chest pain, Vomiting
Clinical narrative: Initial report received from a health care professional on 02 June 2014, via a company representative. A 16-year-old male patient, with no reported medical history, received TYPHIM VI and Yellow Fever vaccines on 29 May 2014 at 9:30 in the morning; lot numbers, routes, and sites of vaccination were not reported. Approximately two hours post-vaccination, at 11:30 in the morning, his mother called the health care professional and stated that the patient had vomited once and was having chest pains. He was instructed to go to the emergency room, where he was suspected to be having an anaphylactic reaction and was treated accordingly. Outcome was not reported. Follow-up information was received on 28 July 2014 from a health care professional. The patient had a history of asthma and NKA. TYPHIM VI, lot number was J1631-1 and it was given IM (intramuscularly) in the left deltoid. Yellow Fever, lot number was UH843AA and it was given SC (subcutaneously) in the right arm. Illness at the time of vaccination was none. Concomitant medication was albuterol PRN. The patient was vaccinated at a public health clinic/hospital and the vaccine was purchased with private funds. No further information was available per the reporter. Outcome was recovered. Documents held by sender: None.
Age: 16.0
Sex: M
Vaccine: TYP, YF, TYP, YF
Symptoms: Anaphylactic reaction, Chest pain, Vomiting
Clinical narrative: Initial report received from a health care professional on 02 June 2014, via a company representative. A 16-year-old male patient, with no reported medical history, received TYPHIM VI and Yellow Fever vaccines on 29 May 2014 at 9:30 in the morning; lot numbers, routes, and sites of vaccination were not reported. Approximately two hours post-vaccination, at 11:30 in the morning, his mother called the health care professional and stated that the patient had vomited once and was having chest pains. He was instructed to go to the emergency room, where he was suspected to be having an anaphylactic reaction and was treated accordingly. Outcome was not reported. Follow-up information was received on 28 July 2014 from a health care professional. The patient had a history of asthma and NKA. TYPHIM VI, lot number was J1631-1 and it was given IM (intramuscularly) in the left deltoid. Yellow Fever, lot number was UH843AA and it was given SC (subcutaneously) in the right arm. Illness at the time of vaccination was none. Concomitant medication was albuterol PRN. The patient was vaccinated at a public health clinic/hospital and the vaccine was purchased with private funds. No further information was available per the reporter. Outcome was recovered. Documents held by sender: None.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Decreased appetite, Erythema, Papule, Pyrexia, Rash pruritic
Clinical narrative: Initial report received from a healthcare professional on 09 June 2012 and follow-up information received on 10 June 2014. A 24-month-old female had received first dose of TYHIM Vi (batch number K1183) intramuscularly in left thigh on 07 June 2014. The patient had no illness at the time of vaccination and any pre-existing allergies, birth defects and medical conditions. The patient did not receive any concomitant medications. On 08 June 2014, one day after vaccination, the patient experienced rash on her abdomen, chest and back and small amount on arms. Rash was mild pruritic. Patient had decreased appetite and vomited once. She also had a low-grade temperature (not measured). There were no changes in stool. The patient was not as playful and energetic as usual. No laboratory tests were performed. The patient was treated with diphenhydramine 2% topical cream for rash. The appetite improved on the day. There was no further N/V. Rash started to diminish and there was no swelling or difficulty breathing. On 09 June 2014, the patient appeared happy, playful, communicative, without itching. There was mild generalized rash on abdomen/chest and back-colorless slightly raised papules s/o erythema barely visible. Face and extremities were clear. Oral cavity/lips was clear without urticarial/hives. Lungs: CTA Heart: RRR Temperature: NL On an unspecified date, the patient had recovered. Documents held by sender: none.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Vomiting
Clinical narrative: Initial report received from a healthcare professional on 09 June 2012 and follow-up information received on 10 June 2014. A 24-month-old female had received first dose of TYHIM Vi (batch number K1183) intramuscularly in left thigh on 07 June 2014. The patient had no illness at the time of vaccination and any pre-existing allergies, birth defects and medical conditions. The patient did not receive any concomitant medications. On 08 June 2014, one day after vaccination, the patient experienced rash on her abdomen, chest and back and small amount on arms. Rash was mild pruritic. Patient had decreased appetite and vomited once. She also had a low-grade temperature (not measured). There were no changes in stool. The patient was not as playful and energetic as usual. No laboratory tests were performed. The patient was treated with diphenhydramine 2% topical cream for rash. The appetite improved on the day. There was no further N/V. Rash started to diminish and there was no swelling or difficulty breathing. On 09 June 2014, the patient appeared happy, playful, communicative, without itching. There was mild generalized rash on abdomen/chest and back-colorless slightly raised papules s/o erythema barely visible. Face and extremities were clear. Oral cavity/lips was clear without urticarial/hives. Lungs: CTA Heart: RRR Temperature: NL On an unspecified date, the patient had recovered. Documents held by sender: none.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Body temperature decreased, Decreased appetite, Energy increased, Rash, Rash papular
Clinical narrative: Initial report received from a healthcare professional on 09 June 2012 and follow-up information received on 10 June 2014. A 24-month-old female had received first dose of TYHIM Vi (batch number K1183) intramuscularly in left thigh on 07 June 2014. The patient had no illness at the time of vaccination and any pre-existing allergies, birth defects and medical conditions. The patient did not receive any concomitant medications. On 08 June 2014, one day after vaccination, the patient experienced rash on her abdomen, chest and back and small amount on arms. Rash was mild pruritic. Patient had decreased appetite and vomited once. She also had a low-grade temperature (not measured). There were no changes in stool. The patient was not as playful and energetic as usual. No laboratory tests were performed. The patient was treated with diphenhydramine 2% topical cream for rash. The appetite improved on the day. There was no further N/V. Rash started to diminish and there was no swelling or difficulty breathing. On 09 June 2014, the patient appeared happy, playful, communicative, without itching. There was mild generalized rash on abdomen/chest and back-colorless slightly raised papules s/o erythema barely visible. Face and extremities were clear. Oral cavity/lips was clear without urticarial/hives. Lungs: CTA Heart: RRR Temperature: NL On an unspecified date, the patient had recovered. Documents held by sender: none.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Rash pruritic, Vomiting
Clinical narrative: Initial report received from a healthcare professional on 09 June 2012 and follow-up information received on 10 June 2014. A 24-month-old female had received first dose of TYHIM Vi (batch number K1183) intramuscularly in left thigh on 07 June 2014. The patient had no illness at the time of vaccination and any pre-existing allergies, birth defects and medical conditions. The patient did not receive any concomitant medications. On 08 June 2014, one day after vaccination, the patient experienced rash on her abdomen, chest and back and small amount on arms. Rash was mild pruritic. Patient had decreased appetite and vomited once. She also had a low-grade temperature (not measured). There were no changes in stool. The patient was not as playful and energetic as usual. No laboratory tests were performed. The patient was treated with diphenhydramine 2% topical cream for rash. The appetite improved on the day. There was no further N/V. Rash started to diminish and there was no swelling or difficulty breathing. On 09 June 2014, the patient appeared happy, playful, communicative, without itching. There was mild generalized rash on abdomen/chest and back-colorless slightly raised papules s/o erythema barely visible. Face and extremities were clear. Oral cavity/lips was clear without urticarial/hives. Lungs: CTA Heart: RRR Temperature: NL On an unspecified date, the patient had recovered. Documents held by sender: none.
Age: 58.0
Sex: M
Vaccine: TYP, YF, TYP, YF
Symptoms: Nausea, Oral herpes
Clinical narrative: Initial report received from a healthcare professional on 26 June 2014. A 58-year-old male patient had received an intramuscular dose of TYPHIM (lot number-J1629, expiry date 13 October 2015) in left deltoid on 19 June 2014 and had received a subcutaneous dose of YF (lot number-UH675AA, 13 March 2015) in left deltoid on 19 June 2014. The patient illness at the time of vaccination was unknown and pre-existing physician diagnosed allergies, birth defects; medical conditions were reported as unknown. On 20 June 2014 i.e. one day after vaccination patient had experienced cold sores in the mouth, which he also had before due to stress. Corrective treatment and laboratory details were not reported. At the time of this report, the outcome of the events was not recovered. Document held by sender: None.
Age: 58.0
Sex: M
Vaccine: TYP, YF, TYP, YF
Symptoms: Oral herpes
Clinical narrative: Initial report received from a healthcare professional on 26 June 2014. A 58-year-old male patient had received an intramuscular dose of TYPHIM (lot number-J1629, expiry date 13 October 2015) in left deltoid on 19 June 2014 and had received a subcutaneous dose of YF (lot number-UH675AA, 13 March 2015) in left deltoid on 19 June 2014. The patient illness at the time of vaccination was unknown and pre-existing physician diagnosed allergies, birth defects; medical conditions were reported as unknown. On 20 June 2014 i.e. one day after vaccination patient had experienced cold sores in the mouth, which he also had before due to stress. Corrective treatment and laboratory details were not reported. At the time of this report, the outcome of the events was not recovered. Document held by sender: None.
Age: 35.0
Sex: F
Vaccine: RAB, TD
Symptoms: Breast tenderness
Clinical narrative: Extreme breast tenderness after the last 2 shots. Even now, weeks later after finishing the series they are still tender. Hurts to press on them and nipples are sensitive. I'm on the Depo shot so I dont get the typical tenderness from menstrual cycle because I no longer have one. The tenderness only began after shot 3 and shot 4 out of the series. It was the post exposure series. I was bitten by a rabies positive dog. I want to know when it will go away.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Cellulitis, Chills, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Fever, chills, pain at site of injection, swollen, warm to touch. Happened about 12-14 hrs later. 10 day antibiotic of Clindamycin 300 mg he thinks for cellulitis.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Fever, chills, pain at site of injection, swollen, warm to touch. Happened about 12-14 hrs later. 10 day antibiotic of Clindamycin 300 mg he thinks for cellulitis.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash, Rash erythematous
Clinical narrative: Reddened and dry "rash" began left posterior shoulder which spread up left side of neck to right side of neck.
Age: 19.0
Sex: M
Vaccine: HEPAB, IPV
Symptoms: Blood thyroid stimulating hormone decreased, C-reactive protein normal, Chronic inflammatory demyelinating polyradiculoneuropathy, Cytomegalovirus test positive, Electromyogram abnormal
Clinical narrative: In early JUL 2014, patient returned to training. (Hx of GBS in APR 2014 VAERS filed. On approximately 10 JUL 2014, patient experienced URI symptoms including cough, runny nose, dull headache, and mild body aches; he did not seek care for these symptoms. On 18 JUL 2014, patient received TWINRIX (dose #2) and IPV vaccines. On 19 JUL 2014, patient awoke with numbness of his hands and feet with mild LE weakness. On 21 JUL 2014, patient sought evaluation for these symptoms, which had not progressed, and was subsequently admitted. During his hospitalization, patient again received a 5-day course of IVIG. His EMG on 22 JUL 2014, showed evidence of acquired SM demyelinating polyradiculopathy of the lower and upper limbs, and his differential diagnosis included recurrent GBS vs. Chronic Inflammatory Demyelinating Neuropathy (CIDP). At time of discharge on 26 JUL 2014, patient's symptoms had nearly resolved except for some paresthesias; his upper and lower extremity strength was reported as 5/5. On 28 JUL 2014, patient reported decreased sensation to palmar aspects of fingers and thumb on both hands, decreased sensation to toes and soles of both feet, and mild weakness of legs. He also felt his gait was slightly impaired due to weakness in his legs. On 18 AUG 2014, patient continued to report tingling in bilateral feet/toes and hands, but no numbness or weakness. By 09 SEP 2014, all of patient's symptoms had resolved. On 17 OCT 2014, a follow-up Neurology evaluation was completed by Dr. At that time, patient's physical exam was normal, but his EMG of bilateral upper and lower limbs was abnormal, showing "electrophysiologic evidence of generalized sensorimotor peripheral neuropathy with demyelinating features." This EMG, however, was significantly improved from his EMG of 22 JUL 2014. In Nov 2014, patient was reassigned and he is currently awaiting physical evaluation. He exercises daily and denies any residual symptoms.
Age: 19.0
Sex: M
Vaccine: HEPAB, IPV
Symptoms: Epstein-Barr virus antibody negative, Gait disturbance, Guillain-Barre syndrome, Hepatitis A antibody positive, Hepatitis B core antibody positive
Clinical narrative: In early JUL 2014, patient returned to training. (Hx of GBS in APR 2014 VAERS filed. On approximately 10 JUL 2014, patient experienced URI symptoms including cough, runny nose, dull headache, and mild body aches; he did not seek care for these symptoms. On 18 JUL 2014, patient received TWINRIX (dose #2) and IPV vaccines. On 19 JUL 2014, patient awoke with numbness of his hands and feet with mild LE weakness. On 21 JUL 2014, patient sought evaluation for these symptoms, which had not progressed, and was subsequently admitted. During his hospitalization, patient again received a 5-day course of IVIG. His EMG on 22 JUL 2014, showed evidence of acquired SM demyelinating polyradiculopathy of the lower and upper limbs, and his differential diagnosis included recurrent GBS vs. Chronic Inflammatory Demyelinating Neuropathy (CIDP). At time of discharge on 26 JUL 2014, patient's symptoms had nearly resolved except for some paresthesias; his upper and lower extremity strength was reported as 5/5. On 28 JUL 2014, patient reported decreased sensation to palmar aspects of fingers and thumb on both hands, decreased sensation to toes and soles of both feet, and mild weakness of legs. He also felt his gait was slightly impaired due to weakness in his legs. On 18 AUG 2014, patient continued to report tingling in bilateral feet/toes and hands, but no numbness or weakness. By 09 SEP 2014, all of patient's symptoms had resolved. On 17 OCT 2014, a follow-up Neurology evaluation was completed by Dr. At that time, patient's physical exam was normal, but his EMG of bilateral upper and lower limbs was abnormal, showing "electrophysiologic evidence of generalized sensorimotor peripheral neuropathy with demyelinating features." This EMG, however, was significantly improved from his EMG of 22 JUL 2014. In Nov 2014, patient was reassigned and he is currently awaiting physical evaluation. He exercises daily and denies any residual symptoms.
Age: 19.0
Sex: M
Vaccine: HEPAB, IPV
Symptoms: Hepatitis B surface antibody positive, Hepatitis C antibody negative, Hypoaesthesia, Immunoglobulin therapy, Mononucleosis heterophile test negative
Clinical narrative: In early JUL 2014, patient returned to training. (Hx of GBS in APR 2014 VAERS filed. On approximately 10 JUL 2014, patient experienced URI symptoms including cough, runny nose, dull headache, and mild body aches; he did not seek care for these symptoms. On 18 JUL 2014, patient received TWINRIX (dose #2) and IPV vaccines. On 19 JUL 2014, patient awoke with numbness of his hands and feet with mild LE weakness. On 21 JUL 2014, patient sought evaluation for these symptoms, which had not progressed, and was subsequently admitted. During his hospitalization, patient again received a 5-day course of IVIG. His EMG on 22 JUL 2014, showed evidence of acquired SM demyelinating polyradiculopathy of the lower and upper limbs, and his differential diagnosis included recurrent GBS vs. Chronic Inflammatory Demyelinating Neuropathy (CIDP). At time of discharge on 26 JUL 2014, patient's symptoms had nearly resolved except for some paresthesias; his upper and lower extremity strength was reported as 5/5. On 28 JUL 2014, patient reported decreased sensation to palmar aspects of fingers and thumb on both hands, decreased sensation to toes and soles of both feet, and mild weakness of legs. He also felt his gait was slightly impaired due to weakness in his legs. On 18 AUG 2014, patient continued to report tingling in bilateral feet/toes and hands, but no numbness or weakness. By 09 SEP 2014, all of patient's symptoms had resolved. On 17 OCT 2014, a follow-up Neurology evaluation was completed by Dr. At that time, patient's physical exam was normal, but his EMG of bilateral upper and lower limbs was abnormal, showing "electrophysiologic evidence of generalized sensorimotor peripheral neuropathy with demyelinating features." This EMG, however, was significantly improved from his EMG of 22 JUL 2014. In Nov 2014, patient was reassigned and he is currently awaiting physical evaluation. He exercises daily and denies any residual symptoms.
Age: 19.0
Sex: M
Vaccine: HEPAB, IPV
Symptoms: Muscular weakness, Mycoplasma test positive, Paraesthesia, Peripheral sensorimotor neuropathy, Red blood cell sedimentation rate normal
Clinical narrative: In early JUL 2014, patient returned to training. (Hx of GBS in APR 2014 VAERS filed. On approximately 10 JUL 2014, patient experienced URI symptoms including cough, runny nose, dull headache, and mild body aches; he did not seek care for these symptoms. On 18 JUL 2014, patient received TWINRIX (dose #2) and IPV vaccines. On 19 JUL 2014, patient awoke with numbness of his hands and feet with mild LE weakness. On 21 JUL 2014, patient sought evaluation for these symptoms, which had not progressed, and was subsequently admitted. During his hospitalization, patient again received a 5-day course of IVIG. His EMG on 22 JUL 2014, showed evidence of acquired SM demyelinating polyradiculopathy of the lower and upper limbs, and his differential diagnosis included recurrent GBS vs. Chronic Inflammatory Demyelinating Neuropathy (CIDP). At time of discharge on 26 JUL 2014, patient's symptoms had nearly resolved except for some paresthesias; his upper and lower extremity strength was reported as 5/5. On 28 JUL 2014, patient reported decreased sensation to palmar aspects of fingers and thumb on both hands, decreased sensation to toes and soles of both feet, and mild weakness of legs. He also felt his gait was slightly impaired due to weakness in his legs. On 18 AUG 2014, patient continued to report tingling in bilateral feet/toes and hands, but no numbness or weakness. By 09 SEP 2014, all of patient's symptoms had resolved. On 17 OCT 2014, a follow-up Neurology evaluation was completed by Dr. At that time, patient's physical exam was normal, but his EMG of bilateral upper and lower limbs was abnormal, showing "electrophysiologic evidence of generalized sensorimotor peripheral neuropathy with demyelinating features." This EMG, however, was significantly improved from his EMG of 22 JUL 2014. In Nov 2014, patient was reassigned and he is currently awaiting physical evaluation. He exercises daily and denies any residual symptoms.